13F filer · CIK 1562230 ↗
Capital International Investors
You are looking at Q3 2023. See the latest, Q2 2026 →
Reported value
$394.11B
−4.9% on the quarter before
Positions
434
20 new · 20 sold out
Top 10
27.2%
of the value
Est. gain
−$13.46B
on stocks held all quarter
Est. return
−3.5%
on those stocks since Q2 2023
Positions as of Sep 30, 2023, from Capital International Investors's 13F filing with the SEC. A 13F lists a manager's US-listed stocks and options at a quarter end and is filed up to 45 days later, so the fund may hold something else today. It leaves out short positions, cash and holdings outside the US.
Portfolio at a glance
- New
- Added
- Cut
- Same
- Options
The 24 largest positions, 44% of the reported value, each sized by its share, colored by what the fund did with it since Q2 2023. Striped tiles are options.
Largest buys
Since Q2 2023, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Cvs Health Corp~$1.40BAdded · 0.0% → 0.4%+20,033,737 shares
- Fedex Corp~$1.08BAdded · 0.1% → 0.4%+4,057,793 shares
- Intel~$865.6MAdded · 0.6% → 0.9%+24,349,192 shares
- Celanese Corp Del~$758.4MAdded · 0.1% → 0.4%+6,042,068 shares
- Apple~$673.1MAdded · 1.3% → 1.4%+3,931,771 shares
- Capital Group Dividend Value~$650.5MAdded · 0.0% → 0.2%+24,575,840 shares
- Pnc Finl Svcs Group Inc~$630.7MAdded · 0.3% → 0.4%+5,137,042 shares
- Rtx Corporation~$622.5MAdded · 1.1% → 1.0%+8,650,010 shares
- Ingersoll Rand Inc~$576.3MNew · 0.0% → 0.1%+9,043,508 shares
- Equifax Inc~$562.6MAdded · 0.6% → 0.6%+3,071,254 shares
Largest sells
Since Q2 2023, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Humana Inc~$1.73BSold out · 0.4% → 0.0%−3,871,317 shares
- Comcast Corp New~$1.49BCut · 1.7% → 1.6%−33,675,660 shares
- Crown Castle Inc~$1.18BCut · 0.4% → 0.0%−12,820,024 shares
- Unitedhealth Group Inc~$1.11BCut · 1.6% → 1.4%−2,205,835 shares
- Seagen Inc~$972.0MCut · 0.3% → 0.1%−4,581,826 shares
- Netflix~$793.9MCut · 1.2% → 0.9%−2,102,618 shares
- Archer Daniels Midland Co~$734.0MCut · 0.3% → 0.1%−9,731,970 shares
- Elevance Health Inc~$681.6MCut · 0.5% → 0.3%−1,564,746 shares
- Meta~$653.6MCut · 2.5% → 2.6%−2,177,208 shares
- Pioneer Nat Res Co~$632.8MCut · 0.4% → 0.3%−2,756,020 shares
Holdings
As of Sep 30, 2023. Changes are in shares against Jun 30, 2023, so a price move alone never reads as a buy or a sale.
| Holding | Value | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| MicrosoftCOM · shares −2.2% · price −7.3% | 6.6% | $25.87B | −$2.03B | ||||||||
| BroadcomCOM · shares −2.6% · price −4.2% | 4.7% | $18.54B | −$821.6M | ||||||||
| AlphabetCAP STK CL C · shares −1.7% · price +9.0% | 2.7% | $10.47B | +$865.0M | ||||||||
| MetaCL A · shares −6.1% · price +4.6% | 2.6% | $10.10B | +$445.7M | ||||||||
| Philip Morris Intl IncCOM · shares −3.6% · price −5.2% | 2.4% | $9.49B | −$516.1M | ||||||||
| MastercardCL A · shares +5.1% · price +0.7% | 2.0% | $8.06B | +$51.1M | ||||||||
| Abbvie IncCOM · shares −1.6% · price +10.6% | 1.6% | $6.33B | +$608.6M | ||||||||
| Comcast Corp NewCL A · shares −20% · price +6.7% | 1.6% | $6.14B | +$386.8M | ||||||||
| Abbott LabsCOM · shares +6.2% · price −11.1% | 1.5% | $6.09B | −$719.0M | ||||||||
| General Electric CoCOM NEW · shares −0.6% · price +0.6% | 1.5% | $5.96B | +$38.1M | ||||||||
| Jpmorgan Chase & CoCOM · shares −4.1% · price −0.2% | 1.4% | $5.71B | −$14.3M | ||||||||
| Unitedhealth Group IncCOM · shares −16% · price +4.9% | 1.4% | $5.71B | +$268.3M | ||||||||
| Transdigm Group IncCOM · shares −0.2% · price −5.7% | 1.4% | $5.54B | −$335.0M | ||||||||
| Northrop Grumman CorpCOM · shares +0.4% · price −3.4% | 1.4% | $5.38B | −$189.6M | ||||||||
| AppleCOM · shares +14% · price −11.7% | 1.4% | $5.33B | −$616.8M | ||||||||
| Visa Inc.COM CL A · shares +9.3% · price −3.1% | 1.3% | $5.14B | −$151.0M | ||||||||
| AmazonCOM · shares +7.5% · price −2.5% | 1.2% | $4.75B | −$112.3M | ||||||||
| Johnson & JohnsonCOM · shares +4.2% · price −5.9% | 1.1% | $4.51B | −$271.6M | ||||||||
| Carrier GlobalCOM · shares +3.2% · price +11.1% | 1.1% | $4.45B | +$429.5M | ||||||||
| Linde PlcSHS · shares −2.5% · price −2.3% | 1.0% | $4.07B | −$95.3M | ||||||||
| Bristol-Myers Squibb CoCOM · shares +0.2% · price −9.2% | 1.0% | $4.03B | −$409.5M | ||||||||
| Rtx CorporationCOM · shares +19% · price −26.5% | 0.99% | $3.89B | −$1.18B | ||||||||
| AlphabetCAP STK CL A · shares −3.0% · price +9.3% | 0.99% | $3.89B | +$331.9M | ||||||||
| Marsh & Mclennan Cos IncCOM · shares −2.3% · price +1.2% | 0.96% | $3.80B | +$46.6M | ||||||||
| SempraCOM · shares +0.5% · price −6.5% | 0.95% | $3.76B | −$261.7M | ||||||||
| Total · 434 positions | 100% | $394.11B | −$13.46B |
Price is a stock's reported value over its shares at the quarter end. The estimated gain is the shares held at both quarter ends times the change in that price: shares bought or sold during the quarter add nothing, options are left out, and a stock split is read into the earlier share count and price.
What made money
From Q2 2023 to Q3 2023: 414 stocks held throughout, down $13.46B (−3.5%).
- Alphabet+$865.0M+9%
- Abbvie Inc+$608.6M+11%
- Constellation Energy Corp+$497.5M+19%
- Charter Communications Inc N+$467.3M+20%
- Meta+$445.7M+5%
- Abbott Labs−$719.0M−11%
- Broadcom−$821.6M−4%
- Dollar Gen Corp New−$965.1M−38%
- Rtx Corporation−$1.18B−27%
- Microsoft−$2.03B−7%
Estimated as in the holdings table: shares held at both quarter ends times the change in price; options left out, 1 split read into the share counts.
Reported value by quarter
The total value of each quarter's 13F at that quarter end. It moves with prices as well as with buying and selling. Pick a quarter to see what the fund held then.
Every quarter's filing
| Quarter | Reported value | Filing | |
|---|---|---|---|
| Q2 2026 | Aug 12, 2026 | $483.61B+13% | SEC ↗ |
| Q1 2026 | May 13, 2026 | $426.52B−33% | SEC ↗ |
| Q4 2025 | Feb 11, 2026 | $637.97B+3% | SEC ↗ |
| Q3 2025 | Nov 13, 2025 | $619.40B+7% | SEC ↗ |
| Q2 2025 | Aug 13, 2025 | $580.56B+14% | SEC ↗ |
| Q1 2025 | May 12, 2025 | $508.52B−4% | SEC ↗ |
| Q4 2024 | Feb 13, 2025 | $532.30B+2% | SEC ↗ |
| Q3 2024 | Nov 13, 2024 | $520.97B+7% | SEC ↗ |
| Q2 2024 | Aug 13, 2024 | $485.73B−2% | SEC ↗ |
| Q1 2024 | May 14, 2024 | $493.90B+11% | SEC ↗ |
| Q4 2023 | Feb 13, 2024 | $446.09B+13% | SEC ↗ |
| Q3 2023 | Nov 13, 2023 | $394.11B−5% | SEC ↗ |
| Q2 2023 | Aug 11, 2023 | $414.45B+7% | SEC ↗ |
| Q1 2023 | May 15, 2023 | $388.71B+4% | SEC ↗ |
| Q4 2022 | Feb 14, 2023 | $372.54B+9% | SEC ↗ |
| Q3 2022 | Nov 14, 2022 | $342.83B−7% | SEC ↗ |
| Q2 2022 | Aug 15, 2022 | $367.64B−16% | SEC ↗ |
| Q1 2022 | May 19, 2022 (amended) | $438.61B−7% | SEC ↗ |
| Q4 2021 | Feb 14, 2022 | $473.03B+8% | SEC ↗ |
| Q3 2021 | Nov 15, 2021 | $437.44B−0% | SEC ↗ |
| Q2 2021 | Aug 16, 2021 | $437.89B+11% | SEC ↗ |
| Q1 2021 | May 14, 2021 | $395.24B+8% | SEC ↗ |
| Q4 2020 | Feb 12, 2021 | $366.38B+13% | SEC ↗ |
| Q3 2020 | Nov 13, 2020 | $323.46B+6% | SEC ↗ |
| Q2 2020 | Aug 14, 2020 | $305.21B+25% | SEC ↗ |
| Q1 2020 | May 15, 2020 | $244.50B−17% | SEC ↗ |
| Q4 2019 | Feb 18, 2020 | $294.42B+12% | SEC ↗ |
| Q3 2019 | Nov 14, 2019 | $261.94B+5% | SEC ↗ |
| Q2 2019 | Aug 14, 2019 | $250.64B+8% | SEC ↗ |
| Q1 2019 | May 15, 2019 | $232.80B+16% | SEC ↗ |
| Q4 2018 | Feb 14, 2019 | $200.60B−8% | SEC ↗ |
| Q3 2018 | Nov 14, 2018 | $218.36B+147% | SEC ↗ |
| Q2 2018 | Aug 14, 2018 | $88.55B+2% | SEC ↗ |
| Q1 2018 | May 15, 2018 | $86.51B−2% | SEC ↗ |
| Q4 2017 | Feb 14, 2018 | $88.52B+6% | SEC ↗ |
| Q3 2017 | Nov 14, 2017 | $83.48B+11% | SEC ↗ |
| Q2 2017 | Aug 14, 2017 | $74.88B+2% | SEC ↗ |
| Q1 2017 | May 15, 2017 | $73.61B+6% | SEC ↗ |
| Q4 2016 | Feb 15, 2017 | $69.28B+0% | SEC ↗ |
| Q3 2016 | Nov 14, 2016 | $68.95B+1% | SEC ↗ |
| Q2 2016 | Aug 15, 2016 | $68.21B+5% | SEC ↗ |
| Q1 2016 | May 16, 2016 | $65.22B | SEC ↗ |